KURT A GUSTAFSON
CIK 1462354 · Executive VP, Finance and CFO · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$521.3K
Companies
5
Total Filings
101
Lifetime Open-Market Net
-$1.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XNCR | Director | 25,011 | $19.97 | $499.5K | -$471.2K | 17 | 2026-07-08 |
| OABIW | Executive VP, Finance and CFO | 261,483 | $0.08 | $21.8K | -$376.2K | 19 | 2026-04-07 |
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | EVP & Chief Financial Officer | 345,417 | $1.03 | $355.8K | -$1.12M | 35 | 2022-03-16 |
| Niagen Bioscience, Inc. (CDXC) Delisted | Director | — | $7.87 | — | $0 | 6 | 2021-06-22 |
| HALOZYME THERAPEUTICS, INC. (HTI) Delisted | Vice President and CFO | 31,709 | — | — | $47.0K | 8 | 2013-02-06 |
Recent Filings · Page 2 of 11
101 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | XNCR | Notice (144) | −2,993 | -$27.5K | EDGAR |
| 2025-06-16 | XNCR | Mixed | +10,693 | -$27.6K | EDGAR |
| 2025-04-07 | OABI | Notice (144) | −7,206 | -$14.4K | EDGAR |
| 2025-04-07 | OABIW | Mixed | +6,336 | -$14.4K | EDGAR |
| 2025-04-01 | OABI | Notice (144) | −11,963 | -$28.4K | EDGAR |
| 2025-04-01 | OABIW | Mixed | +11,281 | -$28.4K | EDGAR |
| 2025-02-19 | OABIW | Mixed | +6,286 | -$26.6K | EDGAR |
| 2025-02-18 | OABI | Notice (144) | −5,188 | -$19.1K | EDGAR |
| 2025-01-22 | OABIW | Mixed | +12,059 | -$50.3K | EDGAR |
| 2025-01-21 | OABI | Notice (144) | −15,526 | -$50.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.